Transcriptional regulation of the β-casein gene by cytokines

Cross- talk between STAT5 and other signaling molecules

Dai Chida, Hiroshi Wakao, Akihiko Yoshimura, Atsushi Miyajima

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The β-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-inducible β-casein expression. However, not only is expression of the β-casein gene regulated by STAT5 but it is also affected by other molecules such as glucocorticoid and Ras. In this report, we describe the transcriptional regulation of the β-casein gene by cytokines in T cells. We have found that the βcasein gene is expressed in a cytotoxic T cell line, CTLL-2, in response to interleukin-2 (IL-2), which activates STAT5. While IL-4 does not activate STAT5, it induces expression of STAT5-regulated genes in CTLL-2, i.e β-casein, a cytokine-inducible SH2- containing protein (CIS), and oncostatin M (OSM), suggesting that STAT6 activated by IL-4 substitutes for the function of STAT5 in T cells. IL-2- induced β-casein expression was enhanced by dexamethasone, and this synergistic effect of Dexamethasone requires the sequence between -155 and - 193 in the β-casein promoter. Coincidentally, a deletion of this region enhanced the IL-2-induced expression of β-casein. Expression of an active form of Ras, Ras(G12V), suppressed the IL-2-induced β-casein and OSM gene expression, and the negative effect of Ras is mediated by the region between -105 and -193 in the β-casein promoter. In apparent contradiction, expression of a dominant negative form of Ras, RasN17, also inhibited IL-2- induced activation of the promoter containing the minimal β-casein STAT5 element as well as the promoters of CIS and OSM. In addition, Ras(G12V) complemented signaling by an erythropoietin receptor mutant defective in Ras activation and augmented the activation of the β-casein promoter by the mutant erythropoietin receptor signaling, suggesting a possible role of Ras in Stat5-mediated gene expression. These results collectively reveal a complex interaction of STAT5 with other signaling pathways and illustrate that regulation of gene expression requires integration of opposing signals.

Original languageEnglish
Pages (from-to)1792-1806
Number of pages15
JournalMolecular Endocrinology
Volume12
Issue number11
DOIs
Publication statusPublished - 1998
Externally publishedYes

Fingerprint

Caseins
Cytokines
Genes
Interleukin-2
Oncostatin M
Erythropoietin Receptors
T-Lymphocytes
Gene Expression
Interleukin-4
Dexamethasone
STAT5 Transcription Factor
Gene Expression Regulation
Glucocorticoids

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism

Cite this

Transcriptional regulation of the β-casein gene by cytokines : Cross- talk between STAT5 and other signaling molecules. / Chida, Dai; Wakao, Hiroshi; Yoshimura, Akihiko; Miyajima, Atsushi.

In: Molecular Endocrinology, Vol. 12, No. 11, 1998, p. 1792-1806.

Research output: Contribution to journalArticle

@article{610dd79467c14dcdb3714321466aa13f,
title = "Transcriptional regulation of the β-casein gene by cytokines: Cross- talk between STAT5 and other signaling molecules",
abstract = "The β-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-inducible β-casein expression. However, not only is expression of the β-casein gene regulated by STAT5 but it is also affected by other molecules such as glucocorticoid and Ras. In this report, we describe the transcriptional regulation of the β-casein gene by cytokines in T cells. We have found that the βcasein gene is expressed in a cytotoxic T cell line, CTLL-2, in response to interleukin-2 (IL-2), which activates STAT5. While IL-4 does not activate STAT5, it induces expression of STAT5-regulated genes in CTLL-2, i.e β-casein, a cytokine-inducible SH2- containing protein (CIS), and oncostatin M (OSM), suggesting that STAT6 activated by IL-4 substitutes for the function of STAT5 in T cells. IL-2- induced β-casein expression was enhanced by dexamethasone, and this synergistic effect of Dexamethasone requires the sequence between -155 and - 193 in the β-casein promoter. Coincidentally, a deletion of this region enhanced the IL-2-induced expression of β-casein. Expression of an active form of Ras, Ras(G12V), suppressed the IL-2-induced β-casein and OSM gene expression, and the negative effect of Ras is mediated by the region between -105 and -193 in the β-casein promoter. In apparent contradiction, expression of a dominant negative form of Ras, RasN17, also inhibited IL-2- induced activation of the promoter containing the minimal β-casein STAT5 element as well as the promoters of CIS and OSM. In addition, Ras(G12V) complemented signaling by an erythropoietin receptor mutant defective in Ras activation and augmented the activation of the β-casein promoter by the mutant erythropoietin receptor signaling, suggesting a possible role of Ras in Stat5-mediated gene expression. These results collectively reveal a complex interaction of STAT5 with other signaling pathways and illustrate that regulation of gene expression requires integration of opposing signals.",
author = "Dai Chida and Hiroshi Wakao and Akihiko Yoshimura and Atsushi Miyajima",
year = "1998",
doi = "10.1210/me.12.11.1792",
language = "English",
volume = "12",
pages = "1792--1806",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Transcriptional regulation of the β-casein gene by cytokines

T2 - Cross- talk between STAT5 and other signaling molecules

AU - Chida, Dai

AU - Wakao, Hiroshi

AU - Yoshimura, Akihiko

AU - Miyajima, Atsushi

PY - 1998

Y1 - 1998

N2 - The β-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-inducible β-casein expression. However, not only is expression of the β-casein gene regulated by STAT5 but it is also affected by other molecules such as glucocorticoid and Ras. In this report, we describe the transcriptional regulation of the β-casein gene by cytokines in T cells. We have found that the βcasein gene is expressed in a cytotoxic T cell line, CTLL-2, in response to interleukin-2 (IL-2), which activates STAT5. While IL-4 does not activate STAT5, it induces expression of STAT5-regulated genes in CTLL-2, i.e β-casein, a cytokine-inducible SH2- containing protein (CIS), and oncostatin M (OSM), suggesting that STAT6 activated by IL-4 substitutes for the function of STAT5 in T cells. IL-2- induced β-casein expression was enhanced by dexamethasone, and this synergistic effect of Dexamethasone requires the sequence between -155 and - 193 in the β-casein promoter. Coincidentally, a deletion of this region enhanced the IL-2-induced expression of β-casein. Expression of an active form of Ras, Ras(G12V), suppressed the IL-2-induced β-casein and OSM gene expression, and the negative effect of Ras is mediated by the region between -105 and -193 in the β-casein promoter. In apparent contradiction, expression of a dominant negative form of Ras, RasN17, also inhibited IL-2- induced activation of the promoter containing the minimal β-casein STAT5 element as well as the promoters of CIS and OSM. In addition, Ras(G12V) complemented signaling by an erythropoietin receptor mutant defective in Ras activation and augmented the activation of the β-casein promoter by the mutant erythropoietin receptor signaling, suggesting a possible role of Ras in Stat5-mediated gene expression. These results collectively reveal a complex interaction of STAT5 with other signaling pathways and illustrate that regulation of gene expression requires integration of opposing signals.

AB - The β-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-inducible β-casein expression. However, not only is expression of the β-casein gene regulated by STAT5 but it is also affected by other molecules such as glucocorticoid and Ras. In this report, we describe the transcriptional regulation of the β-casein gene by cytokines in T cells. We have found that the βcasein gene is expressed in a cytotoxic T cell line, CTLL-2, in response to interleukin-2 (IL-2), which activates STAT5. While IL-4 does not activate STAT5, it induces expression of STAT5-regulated genes in CTLL-2, i.e β-casein, a cytokine-inducible SH2- containing protein (CIS), and oncostatin M (OSM), suggesting that STAT6 activated by IL-4 substitutes for the function of STAT5 in T cells. IL-2- induced β-casein expression was enhanced by dexamethasone, and this synergistic effect of Dexamethasone requires the sequence between -155 and - 193 in the β-casein promoter. Coincidentally, a deletion of this region enhanced the IL-2-induced expression of β-casein. Expression of an active form of Ras, Ras(G12V), suppressed the IL-2-induced β-casein and OSM gene expression, and the negative effect of Ras is mediated by the region between -105 and -193 in the β-casein promoter. In apparent contradiction, expression of a dominant negative form of Ras, RasN17, also inhibited IL-2- induced activation of the promoter containing the minimal β-casein STAT5 element as well as the promoters of CIS and OSM. In addition, Ras(G12V) complemented signaling by an erythropoietin receptor mutant defective in Ras activation and augmented the activation of the β-casein promoter by the mutant erythropoietin receptor signaling, suggesting a possible role of Ras in Stat5-mediated gene expression. These results collectively reveal a complex interaction of STAT5 with other signaling pathways and illustrate that regulation of gene expression requires integration of opposing signals.

UR - http://www.scopus.com/inward/record.url?scp=0031786765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031786765&partnerID=8YFLogxK

U2 - 10.1210/me.12.11.1792

DO - 10.1210/me.12.11.1792

M3 - Article

VL - 12

SP - 1792

EP - 1806

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 11

ER -